Bio-Hybrid Device Acts as "Thermostat" to Control Systemic Inflammation in Sepsis, University of Pittsburgh Study

Published: May 15, 2012

A small, external bioreactor holding human cells pumped out an anti-inflammatory protein to prevent organ damage and other complications in a rat with acute inflammation caused by bacterial products in a model of sepsis, according to a report from researchers at the University of Pittsburgh School of Medicine and the McGowan Institute for Regenerative Medicine. The findings were published today in the inaugural issue of Disruptive Science and Technology.

Back to news